Literature DB >> 10419595

Molecular analysis of multifocal prostate cancer lesions.

E T Ruijter1, G J Miller, C A van de Kaa, A van Bokhoven, M J Bussemakers, F M Debruyne, D J Ruiter, J A Schalken.   

Abstract

To analyse the origin of multifocal prostate cancer lesions, radical prostatectomy specimens from 17 patients were examined. As a marker of genetic lineage, the allelotype based on 33 microsatellite loci was compared between the different tumours present in a given case. Some results provide evidence suggestive of a clonal origin of multiple tumours in a subset of the prostates. In five cases, for example, comparison of multifocal tumour lesions within a given case revealed at least two concordant changes in allelic imbalance (AI) sequence dosages at different loci. In addition, considerable heterogeneity of allelotype was found within and among tumour foci of a given case. In five of the six tumours analysed for intratumour heterogeneity, for example, more than five discordant AI changes were found in one tumour region but not in the other. Conclusions regarding the clonality of such heterogeneous lesions are difficult to draw. A high frequency of AI changes in four lesions exhibiting prostatic intraepithelial neoplasia (mean 6.5 changes per lesion, range 3-6) was found, compared with eight primary tumours present in the same cases (mean 5.8 changes per lesion, range 3-6). The interpretation of AI associated with clinically detected prostate cancer remains a highly complex issue. The fact that no clear evidence was obtained for either a clonal or a non-clonal origin of multiple lesions in a given prostate indicates that several different mechanisms are likely to operate in establishing the allelotype and that additional evidence from unique mutations or selective gene inactivation may be necessary to obtain definitive results. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10419595     DOI: 10.1002/(SICI)1096-9896(199907)188:3<271::AID-PATH359>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Novel approaches for the molecular classification of prostate cancer.

Authors:  Robert H Getzenberg
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

Review 2.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

3.  Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Authors:  Michael C Haffner; Christopher Weier; Meng Meng Xu; Ajay Vaghasia; Bora Gürel; Berrak Gümüşkaya; David M Esopi; Helen Fedor; Hsueh-Li Tan; Ibrahim Kulac; Jessica Hicks; William B Isaacs; Tamara L Lotan; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

4.  Cell-Size Pleomorphism Drives Aberrant Clone Dispersal in Proliferating Epithelia.

Authors:  Subramanian P Ramanathan; Matej Krajnc; Matthew C Gibson
Journal:  Dev Cell       Date:  2019-09-05       Impact factor: 12.270

Review 5.  Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

Authors:  Levent Trabzonlu; Ibrahim Kulac; Qizhi Zheng; Jessica L Hicks; Michael C Haffner; William G Nelson; Karen S Sfanos; Onur Ertunc; Tamara L Lotan; Christopher M Heaphy; Alan K Meeker; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 6.  Clonal origin and spread of metastatic prostate cancer.

Authors:  Jamie L Van Etten; Scott M Dehm
Journal:  Endocr Relat Cancer       Date:  2016-03-21       Impact factor: 5.678

7.  Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.

Authors:  Markos Karavitakis; Hashim U Ahmed; Paul D Abel; Steven Hazell; Mathias H Winkler
Journal:  Ther Adv Urol       Date:  2012-08

Review 8.  Tumor focality in prostate cancer: implications for focal therapy.

Authors:  Markos Karavitakis; Hashim U Ahmed; Paul D Abel; Steven Hazell; Mathias H Winkler
Journal:  Nat Rev Clin Oncol       Date:  2010-11-23       Impact factor: 66.675

9.  Prostate cancer stem cells: do they have a basal or luminal phenotype?

Authors:  Norman J Maitland; Fiona M Frame; Euan S Polson; John L Lewis; Anne T Collins
Journal:  Horm Cancer       Date:  2011-02       Impact factor: 3.869

10.  Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.

Authors:  Allison Young; Nallasivam Palanisamy; Javed Siddiqui; David P Wood; John T Wei; Arul M Chinnaiyan; Lakshmi P Kunju; Scott A Tomlins
Journal:  Am J Clin Pathol       Date:  2012-11       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.